Search results for: Value-Based Pricing
Filter search results
Innovation in Industry: a Factor for Growth
1 July 1969
Over the past few years there has been a growing concern with Britain’s record of industrial innovation based upon technology. This stems from two factors. Firstly, it is increasingly appreciated…
New OHE model estimates COVID-19 could be associated with costs of £7 billion a year in the UK, without annual autumn vaccinations
13 October 2025
…high-risk groups is estimated to save £838 million, averting 12% of the total £7 billion economic burden. Evaluating economic benefits demonstrates the additional value to society of broadening vaccine…
The Burden of Hidradenitis Suppurativa on Patients, the NHS and Society
18 July 2023
…based on the resource utilisation costs directly associated with HS and its associated comorbidities to the NHS, out-of-pocket costs to people living with HS, and productivity losses to wider society….
Incorporating Multiple Criteria in HTA: Methods and Processes
1 March 2011
…approaches to aid decision-making, where decisions are based on more than one criterion, which make explicit the impact on the decision of all the criteria applied and the relative importance…
Forward Together: Complementarity of Public and Charitable Research with Respect to Private Research Spending
9 January 2009
…charitable biomedical research, the debate is particularly intense. This report is based on… The debate continues as to whether public/charitable research replaces private research that otherwise would have occurred, or…
Assessment and Appraisal of Oncology Medicines: NICE’s Approach and International HTA Experience
1 February 2009
…in lower use in the UK. This Report is based on both a… Lower usage of cancer medicines in the UK compared to other countries has created questions, including whether…
Sixty Years of the NHS: Changes in Demographics, Expenditure, Workforce and Family Services
1 September 2008
This series of articles celebrates the 60th anniversary of the UK National Health service (NHS). The series shows how certain areas associated with health have changed over the period. Based…
Martin L. Lee
17 March 2026
…introduction of the first immunotherapeutic for Guillain-Barre Syndrome, the first recombinant DNA-produced Factor VIII preparation for individuals with hemophilia A, the first completely human milk-based fortifier for extremely premature infants,…
The broader economic benefits of COVID-19 vaccination
13 October 2025
…lost productivity. This lost productivity means that COVID-19 infections in the working-age population have a greater impact on the national economy. Using a cost-of-illness analysis based on 2024 cost data,…